By using our website, you agree to the use of our cookies.



  • days
  • Hours
  • Minutes
  • Seconds
🇳🇬 👍 🇳🇬

COVID 19: Another Covid 19 variant B.1.2.5 surfaces in Nigeria and 15 other countries,


The Nigeria Centre for Disease Control (NCDC) announced on Monday that a new COVID-19 variant has been detected in Nigeria and 15 other countries.



The NCDC, the Nigeria Institute of Medical Research (NIMR), and other partners released findings of household seroprevalence surveys (house to house survey) conducted in Lagos, Enugu, Nasarawa and Gombe states between September and October 2020.





NCDC Director-General Dr Chikwe Ihekweazu made the disclosure at the media briefing by the PTF COVID-19.



He explained that the new strain, B.1.2.5, which is different from the highly infectious B.1.1.7 has, however, is not yet tagged a variant of concern.


He said researchers and scientists were still working hard to understand if the B.1.2.5 variant had any effect on the virus transmissibility, immunity, as well as diagnostics, vaccines and therapeutics.





Ihekweazu said: ‘As we shared, a total of 54 cases with the B.1.1.7 variant strain, which is a variant of concern first described in the UK have been detected in Nigeria.


‘There is a new variant, the B.1.2.5 which we have begun to detect in Nigeria and 15 other countries. It is important to note that this variant has not been described as a variant of concern yet.


‘Researchers and scientists are still working hard to understand if this variant has any effect on the virus transmissibility, immunity, as well as diagnostics, vaccines and therapeutics.


‘This is because the variant has some similar mutations with the B.1.1.7, B.1.351 and P.1 variants first detected in the United Kingdom, South Africa and Brazil, respectively.’


The NCDC boss assured that the agency was scaling up its sequencing capacity to have a better understanding of the burden of variants of concern in the country.


Ihekweazu said ‘last week, we sent another 100 samples to our colleagues at the ACEGID lab in Ede, and we did 30 sequences in our lab at NCDC.


‘We will continue to scale the weekly number of samples sequenced as part of our surveillance.’


According to him, the risk of virus mutation was higher when there is high transmission of the virus.


‘While sequencing is important for us to understand the situation, handwashing, physical distancing and the proper use of face masks are very important to prevent the spread of the virus,’ he further stressed.


Speaking on the September and October 2020 household prevalence surveys carried out in Lagos, Enugu, Nasarawa and Gombe states, the NCDC boss said findings revealed the level of SARS-CoV-2 antibodies among the population.


‘The findings from the survey show that the estimated prevalence of SARS-CoV-2 antibodies in the population is 23 per cent in Lagos and Enugu states, 19 per cent in Nasarawa State and 9 per cent in Gombe State’


‘We are still working on a better understanding of SARS-CoV-2 which is the virus that causes COVID-19 and the duration of immunity,’ Ihekweazu said.






Contents provided and/or opinions expressed here do not reflect the opinions of The Pacesetter Frontier Magazine or any employee thereof.

Support The Pacesetter Frontier Magazine

It takes a lot to get credible, true and reliable stories.

As a privately owned media outfit, we believe in setting the pace and leaving strides in time.

If you like what we do, you can donate a token to us here. Your support will ensure that the right news is put out there at all times, reaching an unlimited number of persons at no cost to them.

Related posts

Leave a Reply

Required fields are marked *